PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial, page-136

I dont think Thurn coming back will do it. I'm not convinced he will. Even if he does, the trust in the company is somewhat shattered. It will be yet another effort to restore faith and confidence. Unfortunately, ODD was an opportunity squandered by management goings on. Not irrecoverable, it will just takes time and lots of effort...and the right people. It does need someone like Thurn though.

Early days yet but the funding issue is a major concern. Should have been at the point where many shareholders were confident enough to exercise options...dilution incoming.